Ralliant (NYSE:RAL) Announces Earnings Results

Ralliant (NYSE:RAL) released its earnings results on Tuesday. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08, FiscalAI reports. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The firm had revenue of $534.60 million during the quarter. The firm’s revenue was up 11.0% on a year-over-year basis. Ralliant updated its FY 2026 guidance to 2.530-2.690 EPS and its Q2 2026 guidance to 0.580-0.640 EPS.

Here are the key takeaways from Ralliant’s conference call:

• Ralliant reported a strong Q1 2026 beat across the board, with revenue of $535 million up 11% year over year, adjusted EBITDA margin of 18.6%, and adjusted EPS of $0.57 all above the high end of guidance.
• The company raised full-year 2026 guidance after seeing stronger-than-expected demand, especially in Test and Measurement and defense, with full-year revenue now expected at $2.185 billion-$2.245 billion and adjusted EPS at $2.53-$2.69.
• Defense and Space remains a major growth driver, with over $1 billion in backlog spanning 40+ programs and management saying the business should stay in double-digit growth this year, supported by replenishment demand and modernization spending.
• Test and Measurement returned to growth with 9% organic revenue growth and its highest book-to-bill since 2022, helped by strong demand in communications and diversified electronics, while semiconductors remain temporarily pressured by lapping a large customer project.
• Management announced a new Enterprise Productivity Program targeting $50 million-$60 million of annualized savings by 2028, while also stepping up shareholder returns through a $500 million buyback authorization and plans for a $100 million accelerated share repurchase in Q2.

Ralliant Trading Down 1.5%

Shares of RAL stock traded down $0.94 on Thursday, hitting $60.42. The stock had a trading volume of 855,194 shares, compared to its average volume of 1,721,326. Ralliant has a twelve month low of $37.27 and a twelve month high of $62.35. The firm has a market cap of $6.76 billion and a P/E ratio of -5.52. The company has a current ratio of 1.61, a quick ratio of 0.58 and a debt-to-equity ratio of 0.73. The company has a fifty day moving average price of $44.88 and a two-hundred day moving average price of $47.32.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s payout ratio is 10.20%.

Wall Street Analyst Weigh In

A number of research firms have commented on RAL. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a report on Monday, May 4th. Morgan Stanley lifted their target price on shares of Ralliant from $45.00 to $68.00 and gave the stock an “overweight” rating in a report on Thursday. Royal Bank Of Canada lifted their target price on shares of Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a report on Wednesday. Zacks Research raised shares of Ralliant from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Finally, Barclays lifted their target price on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a report on Wednesday. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.90.

Insider Activity

In other news, SVP Karen M. Bick sold 5,485 shares of the business’s stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the completion of the transaction, the senior vice president owned 46,756 shares of the company’s stock, valued at $2,104,020. The trade was a 10.50% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Hedge Funds Weigh In On Ralliant

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Phocas Financial Corp. raised its holdings in shares of Ralliant by 81.2% in the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock valued at $7,999,000 after purchasing an additional 70,403 shares during the period. Vanguard Group Inc. raised its holdings in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares during the period. Welch & Forbes LLC bought a new stake in shares of Ralliant in the 3rd quarter valued at about $854,000. SG Capital Management LLC acquired a new position in Ralliant in the 3rd quarter valued at about $8,139,000. Finally, Thrivent Financial for Lutherans grew its stake in Ralliant by 60.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 210,045 shares of the company’s stock valued at $9,185,000 after buying an additional 79,173 shares during the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.